Calator

HealthDay – SUNDAY, Aug. 30 (HealthDay News) — A new anti-clotting drug,
ticagrelor (Brilinta), was better than than clopidogrel (Plavix) in
preventing new heart attacks and in reducing deaths among patients who
have had a heart attack, a new study finds.

This entry was posted on Monday, August 31st, 2009 at 10:04 am and is filed under Calator. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.